We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12.8B
AUM Growth
-$896M
Cap. Flow
-$396M
Cap. Flow %
-3.08%
Top 10 Hldgs %
24.99%
Holding
3,035
New
97
Increased
329
Reduced
999
Closed
146

Sector Composition

Rank Sector Weight
1 Technology 25.12%
2 Healthcare 12.03%
3 Financials 11.49%
4 Consumer Discretionary 10.97%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSGS icon
2726
Madison Square Garden
MSGS
$10.6B
$65.1K ﹤0.01%
369
+1
+0.3% +$188
CDXS icon
2727
Codexis
CDXS
$180M
$65K ﹤0.01%
34,375
MEC icon
2728
Mayville Engineering Co
MEC
$605M
$64.4K ﹤0.01%
5,869
TNYA icon
2729
Tenaya Therapeutics
TNYA
$173M
$64.1K ﹤0.01%
25,148
WLFC icon
2730
Willis Lease Finance
WLFC
$1.22B
$63.8K ﹤0.01%
4,527
BEPC icon
2731
Brookfield Renewable
BEPC
$6.5B
$63.2K ﹤0.01%
2,642
+113
+4% +$3.28K
NGVC icon
2732
Vitamin Cottage Natural Grocers
NGVC
$642M
$63.2K ﹤0.01%
+4,897
New +$62.4K
VLD
2733
DELISTED
Velo3D, Inc.
VLD
$62.9K ﹤0.01%
1,152
EVI icon
2734
EVI Industries
EVI
$207M
$62.8K ﹤0.01%
+2,530
New +$63.9K
BIRD icon
2735
Smartbird Inc
BIRD
$29.3M
$62.3K ﹤0.01%
+2,807
New +$75.6K
CNM icon
2736
Core & Main
CNM
$8.61B
$61.7K ﹤0.01%
2,139
+461
+27% +$14.2K
TPG icon
2737
TPG
TPG
$8.18B
$61.6K ﹤0.01%
2,046
+2
+0.1% +$58
CLPT icon
2738
ClearPoint Neuro
CLPT
$463M
$61.4K ﹤0.01%
12,254
CERT icon
2739
Certara
CERT
$1.22B
$60.6K ﹤0.01%
4,166
+3
+0.1% +$50
TDOC icon
2740
Teladoc Health
TDOC
$1.23B
$60.1K ﹤0.01%
3,231
+5
+0.2% +$117
CARM
2741
DELISTED
Carisma Therapeutics
CARM
$60K ﹤0.01%
14,186
MRSN
2742
DELISTED
Mersana Therapeutics
MRSN
$59.2K ﹤0.01%
1,866
CACC icon
2743
Credit Acceptance
CACC
$6.02B
$58.4K ﹤0.01%
127
TPIC
2744
DELISTED
TPI Composites
TPIC
$58K ﹤0.01%
21,871
CRBG icon
2745
Corebridge Financial
CRBG
$15.1B
$57.9K ﹤0.01%
2,933
+4
+0.1% +$74
SIRI icon
2746
SiriusXM
SIRI
$9.6B
$57.7K ﹤0.01%
1,278
+2
+0.2% +$93
STOK icon
2747
Stoke Therapeutics
STOK
$2.14B
$57.6K ﹤0.01%
14,616
FHTX icon
2748
Foghorn Therapeutics
FHTX
$391M
$57.2K ﹤0.01%
11,445
RLYB icon
2749
Rallybio
RLYB
$89.7M
$57.2K ﹤0.01%
2,122
TUSK icon
2750
Mammoth Energy Services
TUSK
$159M
$57.2K ﹤0.01%
+12,318
New +$60K

Similar funds

MetLife Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, MetLife Investment Management held 3,035 positions worth $12.8B, down 6.5% from $13.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management withdrew a net $396M in Q3 2023, closing 146 positions and reducing 999 holdings. Its most notable exit was Accenture, an estimated $57.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Kenvue worth $9.06M.

  • MetLife Investment Management's largest Q3 2023 buy was Kenvue: 451,001 shares worth $9.06M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $37.9M increase.
  • MetLife Investment Management's biggest Q3 2023 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $125M.
  • MetLife Investment Management fully exited Accenture in Q3 2023, selling an estimated $57.6M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.8B portfolio in Q3 2023.
  • MetLife Investment Management opened 97 new positions and closed 146 in Q3 2023.
  • MetLife Investment Management's portfolio value fell 6.5% quarter-over-quarter to $12.8B.

Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.